PHASE II STUDIES
Online First™Investigation of bendamustine HCL in a Phase 2 study in women with resistant ovarian cancer
Amanda F. Baker, Denise J. Roe, Cynthia Laughren, Janice L. Cohen and Heather M. Wright, et al.
Online First™, 13 May 2012
PRECLINICAL STUDIES
Online First™Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines
Brigette B. Y. Ma, Vivian W. Y. Lui, Crystal S. Cheung, Cecilia P. Y. Lau and Kakiu Ho, et al.
Online First™, 8 May 2012
PHASE II STUDIES
Online First™Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer
Keun Seok Lee, In Hae Park, Byung-Ho Nam and Jungsil Ro
Online First™, 5 May 2012
PHASE I STUDIES
Online First™Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole
L. A. Devriese, M. Mergui-Roelvink, J. Wanders, A. Jenner and G. Edwards, et al.
Online First™, 4 May 2012
PRECLINICAL STUDIES
Online First™Inhibitors of cathepsins B and L induce autophagy and cell death in neuroblastoma cells
Donna M. Cartledge, Rita Colella, Lisa Glazewski, Guizhen Lu and Robert W. Mason
Online First™, 2 May 2012
PHASE II STUDIES
Online First™Integrated preclinical and clinical development of S-trans, trans-farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer
Daniel Laheru, Preeti Shah, N. V. Rajeshkumar, Florencia McAllister and Gretchen Taylor, et al.
Online First™, 1 May 2012
PHASE I STUDIES
Online First™Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of MET
Jeffrey R. Infante, Terence Rugg, Michael Gordon, Isabelle Rooney and Lee Rosen, et al.
Online First™, 1 May 2012
PRECLINICAL STUDIES
Online First™Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent
Sang Joon Shin, Jee Won Hwang, Joong Bae Ahn, Sun Young Rha and Jae Kyung Roh, et al.
Online First™, 27 April 2012
PHASE II STUDIES
Online First™A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma
Christopher W. Ryan, Chacon Matias, Mark Agulnik, Antonio Lopez-Pousa and Charles Williams, et al.
Online First™, 27 April 2012
PRECLINICAL STUDIES
Online First™Anti-leukemic effect of 2-pyrone derivatives via MAPK and PI3 kinase pathways
Jin Sun Yoon, Young Woong Won, Seo Ju Kim, Suk Joong Oh and Eun Shil Kim, et al.
Online First™, 23 April 2012